Finding Capital and Controlling Your Agreements

Buchanan Life Sciences Executive Exchange Series – Session 3 Webinar Replay

Danforth’s Daniel Geffken joined panelists from Buchanan, Ingersoll and Rooney and JP Morgan to discuss the all-important subject of capital raising for life science companies. Topics included:

  • The current financing climate; compression between rounds, the rise of the mezzanine round, the accelerated timeline to IPO
  • The changed perception of SPACs – from “back door” to mainstream opportunity
  • How the SPAC process differs from that of a traditional IPO; pros and cons
  • Increased pressure on management teams to get IPO ready; how to prepare

Click here to view the webinar replay.